Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.

Ikegami, Toru

Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. [electronic resource] - Transplantation Aug 2009 - 303-7 p. digital

Publication Type: Journal Article

1534-6080

10.1097/TP.0b013e3181adcae6 doi


ABO Blood-Group System
Adult
Agglutination--drug effects
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20--blood
Blood Group Incompatibility
Blood Grouping and Crossmatching
Catheterization, Peripheral--adverse effects
Combined Modality Therapy
Female
Graft Rejection--blood
Graft Survival--drug effects
Hepatic Artery
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Liver Cirrhosis--blood
Liver Transplantation
Living Donors
Male
Middle Aged
Pilot Projects
Plasma Exchange
Portal Vein
Rituximab
Splenectomy
Time Factors
Treatment Outcome
Young Adult